ETFs: The New Dominant Force in Financial Advisory
Finance

ETFs: The New Dominant Force in Financial Advisory

authorBy Fareed Zakaria
DateAug 27, 2026
Read time2 min

Exchange-Traded Funds (ETFs) are increasingly at the forefront of conversations between financial advisors and their clientele, overshadowing conventional mutual funds and individual stocks and bonds. This marks a significant shift from the financial dynamics observed at the close of the 20th century. The burgeoning influence of ETFs is evident in their sheer numbers and the vast sums they manage.

Focusing on the United States, data from June 30, 2026, reveals a staggering 4,873 ETFs in existence, collectively managing an impressive $15.7 trillion in assets. This substantial growth underscores the shift in investment preferences. Within the realm of equity allocation, dynamic strategies are commonly employed, often manifesting in various forms. The most prevalent factors influencing these rotational strategies typically include market capitalization, the distinction between growth and value investing, and specific industry sector groups.

The rise of ETFs reflects an evolution in investment methodologies and client expectations. Their accessibility, diversification benefits, and often lower expense ratios make them an attractive option for a broad spectrum of investors. As the financial world continues to evolve, understanding the mechanisms and impact of these funds is crucial for both advisors and individuals seeking to optimize their portfolios.

The ascendancy of ETFs represents a positive step towards democratizing finance, offering sophisticated investment tools to a wider audience. Their transparent structure and adaptability provide investors with greater control and insight into their holdings, fostering informed decision-making and promoting a more engaged approach to personal finance.

More Articles
Finance
Veeva Systems: A Robust Outlook Supported by Strong Financials
Veeva Systems is a cloud software leader in the life sciences sector, providing specialized solutions for pharmaceutical and biotech companies. The firm maintains a "Buy" rating due to its consistent double-digit revenue growth, expanding profit margins, and a healthy balance sheet with minimal debt. Its subscription-based model contributes to high gross margins, with first-quarter fiscal year 2027 figures showing 75% GAAP and 86.4% subscription gross margins. Management has revised its fiscal year 2027 guidance upward, aiming for a $6 billion revenue run rate by 2030, with expectations for Q2 revenue to surpass previous forecasts.
By Morgan HouselAug 27, 2026
Finance
S&P 500 Technology Sector: Rebound After Seven-Day Decline
The S&P 500 Technology sector recently concluded a seven-day losing streak, a rare occurrence. Historically, such downturns have often led to positive returns over the medium to long term, with the sector typically rebounding significantly within a year. This recent dip, while notable, was relatively mild compared to more severe historical declines, suggesting potential for recovery.
By Morgan HouselAug 27, 2026
Finance
Navigating the Volatile World of Bond Yields: Key Extremity Bands and Federal Reserve Influence
The bond market is currently a hotbed of activity, with long-end yields declining and swap spreads tightening. This shift is partly a reaction to recent U.S. Treasury actions, but underlying market pressures persist. The upcoming Jackson Hole Symposium could offer temporary relief or a distraction. However, investors will likely soon face the reality that the Federal Reserve's future direction remains unclear, potentially leading to renewed upward pressure on long-end yields.
By Michele FerreroAug 27, 2026
Finance
US Fixed-Income Market Resilience in Q2 2026
In the second quarter of 2026, the US fixed-income markets demonstrated positive performance, driven by diminishing geopolitical tensions and robust economic expansion. Despite rising front-end Treasury yields following the Federal Open Market Committee's actions, the overall market sentiment remained strong. State revenues largely exceeded budget projections, and municipal sectors showcased their ability to adapt to inflationary pressures. The solid issuance trends observed in 2025 continued into the first half of 2026.
By Morgan HouselAug 27, 2026
Finance
TCW Securitized Bond Fund: Performance and Market Outlook
The TCW Securitized Bond Fund I-Class achieved a 0.78% net return in Q2 2026, benefiting from strengthening CLO spreads. With the Federal Reserve expected to maintain current interest rates, the fund emphasizes non-agency MBS and other securitized assets for attractive yields and liquidity. The market outlook is influenced by Middle East geopolitical events affecting energy prices and investor sentiment.
By Mariana MazzucatoAug 27, 2026